Cas:1227608-06-1 2-benzyl-8-oxa-2-azaspiro[4.5]decane-4-carboxylic acid,hydrochloride manufacturer & supplier

Chemical Name:2-benzyl-8-oxa-2-azaspiro[4.5]decane-4-carboxylic acid,hydrochloride

CAS.NO:1227608-06-1

Synonyms:2-Benzyl-8-oxa-2-aza-spiro[4.5]decane-4-carboxylicacid hydrochloride

Molecular Formula:C₁₆H₂₂ClNO₃

Molecular Weight:311.80400

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:49.77000

Exact Mass:311.12900

LogP:2.73970

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-Benzyl-8-oxa-2-aza-spiro[4.5]decane-4-carboxylicacid hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Benzyl-8-oxa-2-aza-spiro[4.5]decane-4-carboxylicacid hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Benzyl-8-oxa-2-aza-spiro[4.5]decane-4-carboxylicacid hydrochloride Use and application,2-Benzyl-8-oxa-2-aza-spiro[4.5]decane-4-carboxylicacid hydrochloride technical grade,usp/ep/jp grade.

Related News: By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed. 2-benzyl-8-oxa-2-azaspiro[4.5]decane-4-carboxylic acid,hydrochloride manufacturer Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037. 2-benzyl-8-oxa-2-azaspiro[4.5]decane-4-carboxylic acid,hydrochloride supplier In recent years, there has been a relatively concentrated concentration of intermediate companies listed on the capital market. Most of the fund-raising projects are aimed at breaking through the bottleneck of production capacity to meet growing demand, and the entire industry has shown a vigorous development momentum. 2-benzyl-8-oxa-2-azaspiro[4.5]decane-4-carboxylic acid,hydrochloride vendor The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. 2-benzyl-8-oxa-2-azaspiro[4.5]decane-4-carboxylic acid,hydrochloride factory By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.